Search Results for: GENE CELL THERAPY Its Growing
Articles
Decibel Therapeutics Announces Extension of Research Term Under Strategic Collaboration With Regeneron to Discover & Develop Gene Therapies for Hearing Loss November 22, 2021
Decibel Therapeutics recently announced that Regeneron has extended the research term of its collaboration with the company to discover and develop gene therapies for hearing loss…..
Catalent's Investment in Expanding its State-of-the-Art Gene Therapy Commercial Manufacturing Campus Increases to $360 Million October 26, 2021
Catalent recently announced a $230-million expansion project to add three further commercial-scale viral vector manufacturing suites and associated support facilities...PolyPid Announces Positive Preclinical Data of its Intra-Tumoral OncoPLEX in Brain Cancer September 14, 2021
PolyPid Ltd. recently announced positive preclinical data in two key Glioblastoma Multiform (GBM) animal models of its OncoPLEX intra-tumoral cancer...Lykan Bioscience & Vineti Announce Partnership to Advance Cell-Based Therapies From Clinical to Commercialization August 17, 2021
Lykan Bioscience and Vineti recently announced a partnership to unite Lykan’s purpose-built cell therapy manufacturing capabilities and Vineti’s industry-leading….
Catalent to Acquire RheinCell Therapeutics, Strengthening a Path Toward Industrialization of Induced Pluripotent Stem Cell-Based Therapies June 29, 2021
Catalent recently announced it has reached an agreement to acquire RheinCell Therapeutics GmbH, a developer and manufacturer of GMP-grade human induced pluripotent stem cells (iPSCs)…..
Genezen Breaks Ground on cGMP Lentiviral Vector Production Facility June 24, 2021
Genezen Laboratories, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) focused on early-phase process development, vector...Bayer to Advance Two First-of-its-Kind Cell & Gene Therapies for Parkinson’s Disease June 9, 2021
Bayer AG recently announced that BlueRock Therapeutics (BlueRock) successfully administered the first dose of its pluripotent stem cell-derived dopaminergic neurons, named DA01, to a….
WEARABLE PLATFORM - Next-Generation Wearable Drug Delivery: Prefilled Devices Provide a Truly Patient-Centric Solution June 2, 2021
Mindy Katz says with increasingly positive expectations for the wearable device market to provide an intuitive and user-friendly drug delivery experience, her company continues to optimize its wearable platform solution, investigating new technologies and processes to improve the offerings for patients and providers.
Catalent Acquires Additional Facility at its Gosselies, Belgium, Campus for Commercial-Scale Plasmid DNA Manufacturing May 6, 2021
Catalent and Promethera Biosciences recently announced that Catalent has acquired Promethera’s cell therapy manufacturing subsidiary, Hepatic Cell Therapy Support SA (HCTS), including its….
Catalent Adds Cryogenic Capabilities at Philadelphia Clinical Supply Services Facility to Meet Growing Demand for Cell & Gene Therapy Development April 21, 2021
Catalent recently announced it has made an investment to expand capabilities at its clinical supply services facility in Philadelphia to...CELL & GENE THERAPY - End-to-End Cell & Gene Therapy – From Development to Commercialization – Buy or Build? March 1, 2021
Aldo Romano and Emily Moran, MBA, discuss how the life science industry must bring technology solutions to the table while at the same time securing the capacity to develop and manufacture groundbreaking cures so patients and society can tap the benefits of cell and gene therapies.
Taysha Gene Therapies Bolsters Manufacturing Capacity Through Partnership November 5, 2020
Taysha Gene Therapies Inc. and Catalent recently announced a partnership to support the development and manufacturing of Taysha’s gene therapies...Catalent to Acquire Cell Therapy Manufacturing Facility From Bone Therapeutics October 29, 2020
Catalent recently announced it had signed an agreement with Bone Therapeutics to acquire its cell therapy manufacturing subsidiary, Skeletal Cell...Bayer Acquires Company to Broaden Innovation Base in Cell & Gene Therapy October 26, 2020
Bayer AG recently announced the acquisition of Asklepios BioPharmaceutical, Inc., a US-headquartered biopharmaceutical company specialized in the research, development, and manufacturing of gene therapies across different therapeutic areas…..
BrainStorm Cell Therapeutics & Catalent Announce Manufacturing Partnership October 22, 2020
Catalent and BrainStorm Cell Therapeutics Inc. recently announced an agreement for the manufacture of NurOwn, BrainStorm’s autologous cellular therapy being investigated for the treatment of….
MilliporeSigma’s New Platform Speeds Development of Cell & Gene Therapies October 14, 2020
MilliporeSigma has recently bolstered its viral vector manufacturing capabilities with the launch of its VirusExpress Lentiviral Production Platform…..
Peptilogics Receives FDA Orphan Drug Designation for Novel Peptide Therapy for the Treatment of Prosthetic Joint Infections September 9, 2020
Peptilogics recently announced that the US FDA has granted Orphan Drug Designation for PLG0206, the company's first-in-class, broad-spectrum antibiotic peptide,...Catalent Invests $130 Million to Add Additional Manufacturing Capacity at its Gene Therapy Campus September 9, 2020
Catalent recently announced it is investing $130 million to add five additional Phase 3 through commercial-scale manufacturing suites to its...Immatics Extends Cell Therapy Manufacturing Collaboration With UTHealth August 7, 2020
Immatics N.V. recently announced the extension of its cell therapy manufacturing collaboration with The University of Texas Health Science Center at Houston (UTHealth)….